【Moderator】

Department of Pediatrics, Japanese Red Cross Medical Center

Keiji Tsuchiya

【Moderator】

Department of Pediatrics, University of California San Diego

Adriana H. Tremoulet

Current status of biologic product clinical trials for acute Kawasaki disease in the U.S.

Lecture1 (Keynote)

Department of Pediatrics, University of California San Diego

Jane C. Burns

Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan

Lecture2

Department of Management and Strategy, Clinical Research Center,National Center for Child Health and Development

Tohru Kobayashi

Therapies targeting TNF-alpha against IVIG resistant Kawasaki disease; infliximab and plasma exchange

Lecture3

Department of Pediatrics, Graduate School of Medicine, Yokohama City University

Shuichi Ito

Progress of a randomized trial of immunoglobulin plus cyclosporin A in patients with Kawasaki disease who are predicted to be non-responders to initial treatment (KAICA Trial)

Lecture4

Chiba University Graduate School of Medicine and Department of Pediatrics,Tokyo Women’s Medical University Yachiyo Medical Center

Hiromichi Hamada

Prospective Observational Study on Efficacy and Safety of Stratified Treatment with Immunoglobulin Plus Steroid for Kawasaki Disease (Post RAISE)

Lecture5

Department of Cardiology, Tokyo Metropolitan Children’s Medical Center

Koichi Miyata